课题基金 / 基金详情

Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts

Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts
人肾同种异体移植物冷藏损伤的机制和离体修复
批准号:
10338146
负责人:
Gregory T Tietjen
金额:
$50.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-28 至 2025-01-31

项目摘要

项目成果

Gregory T Tietjen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The average duration of cold-storage for deceased-donor kidneys in the U.S. can range from ~9 to >30 hrs in the U.S. depending on geographic location. It is well established that the longer a kidney is stored cold prior to transplant, the greater the likelihood of post-transplant complications like delayed graft function. This is particularly true for organs from aging donors or donors with co-morbidities—an ever-expanding proportion of the U.S. donor pool—which display increased sensitivity to injury during cold storage. Little is known about the mechanisms that determine the rate and extent of cold-storage injury in human organs. This lack of knowledge presents a critical barrier to the development of therapeutic strategies to reduce the clinical impact of cold-storage injury. We have recently discovered that cold storage induces human kidneys to produce fibrinogen within renal tubular cells. Upon restoration of normothermia/normoxia, fibrinogen is secreted into the vasculature where it can aggregate erythrocytes in a rouleaux formation leading to pathologic plugging of microvessels. We hypothesize that renal fibrinogen is a major effector of cold-storage injury and therefore represents a viable target to improve organ resilience after cold storage. Ex Vivo Organ Perfusion (EVOP) has emerged as a research and clinical platform providing an opportunity to directly test this hypothesis in a translationally relevant setting. Here, we will exclusively use human tissues to achieve two objectives: 1) Determine the mechanism by which cold- storage induces renal fibrinogen synthesis; and 2) Evaluate EVOP as a therapeutic platform to ameliorate fibrinogen-mediated pathology pre-transplant. Successful completion of these objectives will establish a new paradigm for prevention of cold-storage-induced organ injury with the potential to save patient lives by improving both access to organs and post-transplant outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Redefining the limits of tolerable warm ischemia in deceased donor kidneys
  • 批准号:
    10368145
  • 项目类别:
  • 资助金额:
    $25.13万
  • 财政年份:
    2021
  • 负责人:
    Gregory T Tietjen
  • 依托单位:
Redefining the limits of tolerable warm ischemia in deceased donor kidneys
  • 批准号:
    10195912
  • 项目类别:
  • 资助金额:
    $20.94万
  • 财政年份:
    2021
  • 负责人:
    Gregory T Tietjen
  • 依托单位:
Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts
  • 批准号:
    10116374
  • 项目类别:
  • 资助金额:
    $50.98万
  • 财政年份:
    2020
  • 负责人:
    Gregory T Tietjen
  • 依托单位:
Targeted nanoparticle delivery of PNA anti-miRs to quiesce inflamed endothelium
  • 批准号:
    9404511
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2016
  • 负责人:
    Gregory T Tietjen
  • 依托单位:
海外基金